[1]王丽娜,李亦蕾,王煜昊,等.我国短缺药品的采购方式及优化研究[J].卫生经济研究,2024,41(02):36-40.
　WANG Lina,LI Yilei,WANG Yuhao,et al.Study on the Procurement Model and Optimization of Drug Shortage in China[J].Journal Press of Health Economics Research,2024,41(02):36-40.
点击复制

我国短缺药品的采购方式及优化研究
分享到：

卫生经济研究[ISSN:1004-7778/CN:33-1056/F]

卷:
41
期数:
2024年02期
页码:
36-40
栏目:
药械管理
出版日期:
2024-01-30

文章信息/Info

Title:
Study on the Procurement Model and Optimization of Drug Shortage in China
作者:
王丽娜1; 李亦蕾2; 王煜昊1; 树婷婷1; 梁丽蕙1; 黄晓青1; 徐 伟1
1.中国药科大学国际医药商学院，江苏 南京 211198
2.南方医科大学南方医院，广东 广州 510515
Author(s):
WANG Lina;  LI Yilei;  WANG Yuhao;  SHU Tingting;  LIANG Lihui;  HUANG Xiaoqing;  XU Wei
School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing Jiangsu 211198, China
关键词:
短缺药品; 直接挂网; 带量采购; 采购规则
Keywords:
shortages of drugs;  direct listing;  volume-based procurement;  procurement rules
分类号:
R19
文献标志码:
A
摘要:
目的：分析我国短缺药品的采购方式，为优化短缺药品采购政策提供建议。方法：从采购价格、采购量、采购周期等方面，分析短缺药品直接挂网、备案采购和带量采购方式存在的问题。结果：直接挂网和备案采购模式下，企业生产供应积极性有待提高，药品涨价和临床用量小所致的药品短缺问题难以解决；带量采购药品遴选标准不明晰，成交参考价的合理性有待商榷，药品采购量难以确定。结论：为做好短缺药品保供稳价工作，需明确短缺药品分类采购情形，合理制定短缺药品采购价格，确定短缺药品采购需求量。
Abstract:
Objective To analyze the procurement methods of drugs in shortage in China, and to provide suggestions for optimizing the procurement policy of drugs in shortage. Methods From the aspects of procurement price, procurement volume and procurement cycle, the problems of direct listing, filing procurement and volume-based procurement of drugs in shortage were analyzed. Results Under the direct listing and filing procurement modes, the enthusiasm of enterprises in production and supply should to be improved, and it was difficult to solve the problem of drug shortages due to price increase and small clinical dosage. The selection criteria for volume-based procurement of drugs were unclear, the reasonableness of the transaction reference price was open to question, and it was difficult to determine the quantity of drugs to be purchased. Conclusion In order to ensure the supply and stabilize the price of drugs in short supply, it is necessary to clarify the categorization and procurement, rationally set the procurement price and determine the procurement demand.

参考文献/References:

[1] 马利云，马源源，汪汉香，等.湖北省药品短缺的原因及应对策略[J].医学与社会，2020，33（08）：34-38.
[2] 李静，陈文，蒋虹丽.短缺药品供应保障的地方实践进展及启示[J].中国卫生资源，2021，24（04）：472-475，487.
[3] 桑文涛，尚天琼，吕涯行，等.患者健康权视域下医院短缺药品供应保障相关问题及对策研究[J].中国药事，2022，36（06）：672-678.
[4] 朱雅萌，傅鸿鹏.我国短缺药品现状分析与思考[J].卫生经济研究，2021，38（06）：59-62.
[5] 汤理帆.药品短缺现状分析及对策研究[D].昆明：昆明理工大学，2022.
[6] 范嘉宁，黄佳欣，刘新颖，等.基于多角度的短缺药品保供稳价政策效果研究[J].沈阳药科大学学报：1-9.
[7] 黄哲，于钟怡，兰毅鹏，等.辽宁省短缺药品监测评价模型的构建研究[J].沈阳药科大学学报，2022，39（08）：1010-1017.
[8] 张燊，何江波.全国8个省短缺药品清单分析及其集中采购策略研究[J].昆明学院学报，2021，43（03）：128-132.
[9] 金丽君.准公共品视角下的上海市短缺药品“保供稳价”机制优化研究[D].上海：上海财经大学，2020.

相似文献/References:

[1]邵 蓉,孙海顺,张 梦.英国短缺药品联络人报告制度对我国的启示[J].卫生经济研究,2016,(12):22.
[2]李 勇,赵梦蕊,马爱霞,等.我国仿制药一致性评价对药品短缺的影响分析[J].卫生经济研究,2017,(05):47.
[3]盛亚楠,李 勇,马爱霞,等.我国短缺药品供应保障政策研究[J].卫生经济研究,2017,(08):57.
[4]葛 靖,王淑庆,常 峰,等.上海市短缺药品特点及使用变化情况研究[J].卫生经济研究,2020,(02):59.
　GE Jing,WANG Shu-qing,CHANG Feng,et al.Study on the Characteristics and Changes of Drugs in Shortage in Shanghai[J].Journal Press of Health Economics Research,2020,(02):59.
[5]朱雅萌,傅鸿鹏.我国短缺药品现状分析与思考[J].卫生经济研究,2021,38(6):59.
　ZHU Ya-meng,FU Hong-peng.Analysis and Reflection on the Current Situation of Drug Shortage in China[J].Journal Press of Health Economics Research,2021,38(02):59.
[6]俞心怡,吴 培,胡楠清,等.短缺药品储备政策的实施现状与优化——以江苏省为例[J].卫生经济研究,2021,38(11):29.
　YU Xin-yi,WU Pei,HU Nan-qing,et al.Implementation Status and Optimization of Shortage Drug Reserve Policy——A Case Study of Jiangsu Province[J].Journal Press of Health Economics Research,2021,38(02):29.

更新日期/Last Update: 2024-01-30